Product
Autologous CIK
1 clinical trial
1 indication
Indication
SarcomaClinical trial
A Phase I Study of Adoptive Immunotherapy With Cytokine-Induced Killer Cells in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.Status: Completed, Estimated PCD: 2023-03-16